HLA Typing Market

HLA Typing Market Size, Market Forecast and Outlook By FMI

The hla typing market was valued at USD 1.30 billion in 2025, projected to reach USD 1.39 billion in 2026, and is forecast to expand to USD 2.65 billion by 2036 at a 6.70% CAGR. As per FMI, the incremental opportunity across the forecast period amounts to USD 1.27 billion, reflecting a steady expansion trajectory shaped by evolving end-use requirements and shifting procurement patterns across global supply chains.

Expanding organ and stem cell transplantation volumes, growing pharmacogenomic testing adoption, and advancing molecular assay precision are driving procurement growth for human leukocyte antigen (HLA) typing products across transplant centers, research laboratories, and commercial service providers. Next-generation sequencing-based HLA typing is progressively displacing lower-resolution serological methods as transplant programs mandate allele-level resolution to optimize donor-recipient matching and reduce graft rejection risk. As per FMI, the molecular assay technique commands the leading share as sequenced-based and PCR-based HLA typing deliver the allele-level resolution required by current transplant matching algorithms.

Summary of HLA Typing Market

• The market is estimated at USD 1.30 billion in 2025.
• The market is projected to reach USD 2.65 billion by 2036.
• The market is expected to grow at a CAGR of 6.70% from 2026 to 2036.
• The forecast period represents an incremental opportunity of USD 1.27 billion.
• Reagents & consumables lead by product type with a 46.7% share in 2026.
• Diagnosis dominates by application with a 59.3% share in 2026.
• The market is driven by increasing transplant volumes and adoption of high-resolution HLA typing technologies.
• Product scope includes reagents, instruments, and software/services for diagnostic and research applications.
• China (7.1%) and the USA (6.9%) are among the fastest-growing markets.
• Key companies in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., bioMerieux S.A., CareDx, Inc., Hologic, Inc., and Olerup International AB.

HLA Typing Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 1.39 Billion
Industry Value (2036)	USD 2.65 Billion
CAGR (2026-2036)	6.70%

Source: Future Market Insights, 2026

Regional demand for HLA typing products reflects the geographic distribution of transplant program activity, donor registry size, and pharmacogenomic research investment. China at 7.1% CAGR, USA at 6.9% CAGR, Japan at 6.5% CAGR, UK at 5.8% CAGR, South Korea at 4.7% CAGR. China leads growth through expanding organ transplant program capacity and national donor registry development. India follows on the strength of growing stem cell transplant volumes and diagnostic laboratory modernization. Germany sustains growth through its position as a major bone marrow donor registry operator and precision transplant medicine center. The United States advances through large-scale transplant program procurement and pharmacogenomic research funding. The United Kingdom maintains growth through NHS transplant service modernization and research council investment.

Based on FMI's report, the hla typing market is expected to create an incremental opportunity of USD 1.27 billion between 2026 and 2036. FMI analysts project that end-use procurement patterns and regional supply chain dynamics will shape the distribution of this opportunity across segments and geographies.

HLA Typing Market Definition

HLA typing is the laboratory process of identifying human leukocyte antigen alleles on an individual's cells, primarily for organ and stem cell transplant donor-recipient matching, disease association research, and pharmacogenomic testing. Product categories include reagents and consumables, instruments (sequencers, PCR systems), and software and services. Typing techniques span molecular assays (sequence-based typing, PCR-SSP, PCR-SSO) and non-molecular assays (serological methods). These products are deployed across commercial typing service providers, transplant centers, hospitals, research laboratories, and academic institutes.

Future Market Insights analysis captures the complete addressable consumption base across all major producing and consuming regions, covering the forecast period from 2026 to 2036.

HLA Typing Market Inclusions

Market scope includes HLA typing reagents, instruments, and software/services across molecular and non-molecular techniques for diagnostic and research applications. The assessment covers global and regional market sizes, forecast period 2026 to 2036, and segment breakdowns by product type, application, technique, end user, and region.

HLA Typing Market Exclusions

The scope excludes general immunology reagents, flow cytometry instruments not dedicated to HLA analysis, organ preservation solutions, and transplant surgical equipment. Donor recruitment and registry administration costs are not included.

HLA Typing Market Research Methodology

• Primary Research: Analysts engaged with procurement managers, clinical specialists, and distribution channel executives to map the decision gates and compliance thresholds shaping product adoption.
• Desk Research: Data collection aggregated regulatory filings, clinical guidelines, trade body publications, and company financial disclosures across all major producing and consuming regions.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of product shipment volumes and utilization data, applying region-specific adoption growth curves to project demand velocity through 2036.
• Data Validation and Update Cycle: Projections are tested against publicly reported industry statistics, clinical data, and company guidance. The model is updated quarterly to reflect market structure changes.

Consumption Patterns and Volume Analysis of HLA Typing Solutions

• The demand for HLA testing is increasing as it finds usage in multiple applications. Integrating HLA typing in personalized immunotherapy is a significant advancement and is expected to be a breakthrough in the field. This integration can help HLA testing professionals fill global gaps in human leukocyte antigen libraries and identify HLA variants associated with diseases. Advancements in this area can further improve the accuracy of HLA typing for vaccine design and organ transplants.
• In the forecasted period, the most significant technology segment in the human leukocyte antigen (HLA) typing for transplant market is represented by molecular assays. This is due to the advantages provided by molecular assays, including high procedural efficacy, real-time sample analysis, low turnaround time, and the ability to analyze multiple samples.
• The incorporation of HLA typing in personalized immunotherapy is a significant advancement that can aid HLA testing professionals in filling gaps in human leukocyte antigen libraries worldwide and identifying human leukocyte antigen variants in diseases. Additionally, progress in this field may improve HLA typing accuracy for organ transplants and vaccine development.
• Over a while, the procedure of screening the donor and recipient involved using serology-based assays before undergoing a transplantation procedure. However, gene-based histocompatibility testing methods are preferred to serology-based assays. The molecular assay takes less time for analysis, has higher sample throughput, can handle several samples in a single run, and requires fewer patient samples than serology assay techniques. As a result, the adoption of molecular assay technologies for HLA profiling in transplant donor patients is increasing.

Top Product-Type Insights Shaping HLA Typing Equipment Development

Increasing Prevalence of Instruments in Transplantation is Driving the HLA Typing Market

The global HLA typing market has three categories based on the type of products - instruments, reagents and consumables, and software and services. The instruments segment is perfect for organ transplantation procedures of the vital organs.

The instruments segment held a CAGR of 8.0% from 2021 to 2026. The software and services segment is anticipated to catch up to the instruments segment in terms of value as organ transplantation, disease diagnosis, and personalized medicines expand during the research period. In the upcoming decade, the instruments segment has been supposed to dominate the market, according to a global CAGR of 6.5%.

Top Product	Instruments
CAGR %	8.0% CAGR
CAGR % 2026 to End of Forecast (2036)	6.5% CAGR

Application-Wise Insights into HLA Typing Demand

Diagnostics Segment Accounted for the Highest Market Share With A CAGR of 7.7%

During the forecast period, the global HLA typing transplant market is segmented into diagnostics and research, with the diagnostics segment accounting for a leading market share in 2026, with a CAGR of 7.7%. This can be attributed to the trend among hospitals and transplant centers to outsource laboratory services, as well as the increase in diagnostics laboratories merging.

Hospitals and transplant centers collaborate with diagnostic labs to perform diagnostic tests that can diagnose diseases such as Behcet's disease, rheumatoid arthritis, and narcolepsy, which can accelerate the market for HLA typing. The research segment is expected to experience significant growth during the forecast period.

Top Application	Diagnosis
CAGR %	7.7% CAGR
CAGR % 2026 to End of Forecast (2036)	6.3% CAGR

Country-wise Analysis of HLA Typing Market Growth

Expansion of the HLA Typing Market Across the United States

The HLA typing market in the United States generated revenue of USD 2.4 million in 2036. The market may grow significantly in the coming years, with an expected CAGR of 6.9% from 2026 to 2036. The United States dominates the market due to the rise in demand for organ transplants and the government's support to encourage growth in programs for organ donation and transplantation.

Country	United States
CAGR (2021 to 2026)	8.7%
CAGR (2026 to 2036)	6.9%

Surging Demand for HLA Typing Procedures in the United Kingdom

The United Kingdom is expected to dominate the market growth during the forecast period, thanks to the high adoption of advanced technologies and the increasing prevalence of the disease. These factors are expected to drive the development of the regional market in the United Kingdom. The HLA typing market in the United Kingdom is anticipated to deliver a market share of 69.3 million with a CAGR of 5.8% in the upcoming decade.

Country	United Kingdom
CAGR (2021 to 2026)	6.6%
CAGR (2026 to 2036)	5.8%

Pivotal Role of China in the Advanced HLA Typing Market

By 2026, the HLA typing industry in China is expected to experience a significant growth rate of 9.5%. The demand for HLA typing is predicted to continuously increase, with a compound annual growth rate of 7.1% over the next ten years. This growth is attributed to the improved infrastructure of healthcare facilities, expanding economic factors, and well-designed reimbursement policies, which are having a positive impact on the development of the market.

Country	China
CAGR (2021 to 2026)	9.5%
CAGR (2026 to 2036)	7.1%

Japan Considerably Holds a Lucrative Position in the HLA Typing Market

In the upcoming years, the market for HLA typing in Japan is expected to experience significant growth. This is attributed to the development of technical and healthcare sectors in producing provinces. It is anticipated that the demand for HLA typing in Japan is likely to register a growth of 7.6% between 2026 and 2036. The healthcare sector's growing demand for HLA typing is expected to propel market growth in the next decade.

Country	Japan
CAGR (2021 to 2026)	9.3%
CAGR (2026 to 2036)	6.5%

The Dominance of the HLA Typing Technology in South Korea

The market for HLA typing in South Korea is expected to evolve rapidly in the coming years. This is due to the development of the technical and healthcare sectors in developing provinces. The demand for HLA typing in South Korea is projected to record a CAGR of around 4.7% from 2026 to 2036. The healthcare sector's increasing need for HLA typing is expected to drive market growth in the next decade.

Country	South Korea
CAGR	5.2%
CAGR (2026 to 2036)	4.7%

Competitive Landscape of the Global HLA Typing Industry

HLA typing is increasingly essential in healthcare, providing benefits such as improved outcomes in organ transplantation, personalized medicine, better diagnosis and treatment of diseases, and scientific research opportunities. Key players in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, and Illumina Inc., which use organic and inorganic growth strategies to expand their consumer base.

Scope of the Report

Metric	Value
Quantitative Units	USD 1.39 Billion to USD 2.65 Billion, at a CAGR of 6.70%
Market Definition	HLA typing is the laboratory process of identifying human leukocyte antigen alleles on an individual's cells, primarily for organ and stem cell transplant donor-recipient matching, disease association research, and pharmacogenomic testing. Product categories include reagents and consumables, instruments (sequencers, PCR systems), and software and services.
Segmentation	Product Type: Reagents & Consumables, Instruments, Software & Services; Application: Diagnosis, Research; Technique: Molecular Assay, Sequenced-based Molecular Assay, Non-molecular Assay; End User: Commercial Service Providers, Hospitals, Transplant Centers, Research Labs, Academic Institutes
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	China, USA, Japan, UK, South Korea, and 40 plus countries
Key Companies Profiled	Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., F.Hoffmann-La Roche Ltd., Immucor, Inc., bioMerieux S.A., CareDx, Inc., Hologic, Inc., Olerup International AB
Forecast Period	2026 to 2036
Approach	Forecasting models apply a bottom-up methodology starting with regional utilization metrics and projecting adoption rates against demand drivers and regulatory frameworks.

Market Segmentation of HLA Typing Industry

By Product Type:

• Instruments
• Reagents & Consumables
• Software & Services

By Application:

• Diagnosis
• Research

By Technique:

• Molecular Assay
• Sequenced-based Molecular Assay
• Non-molecular Assay

By End User:

• Commercial Service Providers
• Hospitals
• Transplant Centers
• Research Labs
• Academic Institutes

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East & Africa

Bibliography

• World Health Organization. (2025). WHO Guiding Principles on Human Cell, Tissue, and Organ Transplantation. WHO.
• European Federation for Immunogenetics. (2025). EFI Standards for Histocompatibility and Immunogenetics Testing. EFI.
• USA Department of Health and Human Services. (2025). Organ Procurement and Transplantation Network Data. HRSA.
• International Society for Heart and Lung Transplantation. (2025). ISHLT Registry Reports. ISHLT.
• Illumina Inc. (2025). Annual Report 2025. Illumina.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.